|
|
Дата на влизане (въвеждане) |
| 4945 |
Iloprost 100 micrograms/ml concentrate for solution for infusion - Summary of Product Characteristics Updated 12-Oct-2023. Colonis Pharma Ltd |
01/06/2025 |
| 4943 |
Stability of Nine Time-Dependent Antibiotics for Outpatient Parenteral Antimicrobial Therapy (OPAT) Use Antibiotics |
21/05/2025 |
| 4942 |
Elranatamab (ELREXFIO) - Information Médicale PFIZER Pfizer |
19/05/2025 |
| 4935 |
Physicochemical stability of mixtures of nonsteroidal anti-inflammatory drugs such as ketorolac and diclofenac and antiemetics such as ondansetron and ramosetron: an in vitro study. Korean J Pain |
23/04/2025 |
| 4936 |
Stability of Daptomycin in Dextrose and Icodextrin-Based Peritoneal Dialysis Solutions. Can J Anesth |
23/04/2025 |
| 4932 |
Physical stability of bevacizumab solutions for intravitreal injections: Influence of conditioning material and storage conditions. Pharmaceuticals |
21/04/2025 |
| 4928 |
Compatibility tests - march 2025. Newsletter INFOSTAB 68 - march 2025 |
07/04/2025 |
| 4929 |
Long-term Physicochemical Stability of a Pharmaceutical Preparation of Morphine Hydrochloride and Droperidol in Polypropylene Syringes. Int J Pharm Compound |
07/04/2025 |
| 4931 |
Compatibility of Active Pharmaceutical Ingredients Combinations Compounded in Cleoderm, a Cream Base for Personalized Dermatological Treatments. Int J Pharm Compound |
07/04/2025 |
| 4924 |
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings EJHP |
26/03/2025 |
| 4921 |
Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride, Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions. Int J Pharm Compound |
12/03/2025 |
| 4920 |
Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel. Pharmaceuticals |
04/03/2025 |
| 4919 |
Dostarlimab (Jemperli®) – Résumé des caractéristiques du produits |
03/03/2025 |
| 4917 |
A Physicochemical Stability Study of Pembrolizumab Vial Leftovers: Let Us Stop Pouring Good Money Down the Drain. Pharmacy |
18/02/2025 |
| 4916 |
Stability Over Time of In-Hospital-Compounded Amoxicillin Capsules and Ceftriaxone Patch Tests for Drug Allergy Testing. J Investig Allergol Clin Immunol |
16/02/2025 |
| 4914 |
In‐Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions. Drugs R D |
02/02/2025 |
| 4911 |
Glofitamab (Columvi®) - Résumé des caractéristiques du produit |
28/01/2025 |
| 4912 |
Tafasitamab (Minjuvi®) - Résumé des caractéristiques du produit Incyte Biosciences |
28/01/2025 |
| 4913 |
Teclistamab (Tecvayli®) - Résumé des caractéristiques du produit Janssen-Cilag International NV |
28/01/2025 |
| 4904 |
Y-site simulation compatibility study of 10% calcium salts with various injectable solutions during toxicological resuscitation. EJHP |
15/01/2025 |
| 4905 |
Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration Pharmaceuticals |
15/01/2025 |
| 4893 |
Stability and Sterility of Extemporaneously Prepared .01% Atropine Ophthalmic Solution in Artificial Tears and Balanced Salt Solution. Siriraj Medical Journal |
07/01/2025 |
| 4894 |
Chemical stability of pharmacy-compounded cefazolin sodium eye drops. Pharm Chem J |
07/01/2025 |
| 4895 |
Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial for Cost Savings. JCO Oncology Practice |
07/01/2025 |
| 4891 |
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophtalmol Ther |
06/01/2025 |
| 4892 |
Combined physicochemical and functional assessment of pertuzumab integrity supports extended in‐use stability. Arch Pharm |
06/01/2025 |
| 4888 |
Stabilité du propofol, du rocuronium, du phénobarbital et du magnésium injectables reconditionnés en seringue pour les trousses d’aide médicale à mourir. Pharmactuel |
01/01/2025 |
| 4887 |
IMJUDO (tremelimumab) 20 mg/mL concentrate for solution for infusion. Summary of Product Characteristics. Astra Zenaca AB |
14/12/2024 |
| 4886 |
Physicochemical and Microbiological Stability of Ursodiol Oral Compounded Suspensions. J Pediatr Pharmacol Ther |
11/12/2024 |
| 4884 |
Stability of Diluted Desmopressin Acetate Intranasal Solution at 0.01 mg/mL. Int J Pharm Compound |
06/12/2024 |
